Christina E. Hoeve1,2 · Reynold D. C. Francisca1,2 · Inge Zomerdijk1,2 · Miriam C. J. M. Sturkenboom3
Sabine M. J. M. Straus1,2
Published online: 16 October 2019
© The Author(s) 2019

Introduction :  Medication errors can have serious consequences for patients. To prevent the occurrence of medication errors in clinical practice, safety concerns may be included in the risk management plan and subsequently be addressed with routine and/or additional risk minimisation measures.

Objective :This study aims to describe safety concerns around medication errors and the risk minimisation measures for centrally authorised products in the European Union.


WHITEPAPER: Description of the Risk Management of Medication Errors for Centrally Authorised Products in the European Union